Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C
US11905523B2 · kind B2 · utility
0Cited by
122References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2020 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Dec 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are gene therapy compositions and methods for treating, preventing, and/or curing NPC1. More specifically, the disclosure provides Adeno-associated virus (AAV) vectors for delivery of nucleic acids and nucleic acids (including AAV transfer cassettes) for treating, preventing, and/or curing NPC1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.